Pacific Biosciences makes DNA sequencing systems, reagents and services for researchers, clinical labs and drug developers. It last closed at $1.63 on Nov 20, down 7.39% on the day. The next earnings report for PACB is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, PACB reported EPS of -$0.12 on revenue of $40.6M, with revenue up 5.5% from a year ago. Over its last 8 reports the stock moved an average of 9.4% the session after earnings. Over the last 12 months PACB insiders bought $0 of stock on the open market and sold $3.4M, according to SEC Form 4 filings.
AI Auto Pilots
Is PACB in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold PACB.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on PACBStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
PACB · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, nearing oversold
The stock is 37% below its 20 day and 26% below its 50 day average. It is 2% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 35), near oversold. The nearest support is the 200 day average at $1.60, and the nearest resistance the Pivot at $1.66.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityHigh, 15.1%/day
Key levels
$3.4452 week high+111.0%
$2.2320 day average+36.8%
$2.0550 day average+25.8%
$1.77Swing high (Jun 4)+8.6%
$1.71100 day average+4.9%
$1.70Pivot R1+4.3%
$1.66Pivot+1.8%
$1.63Last close
$1.60200 day average−1.8%
$1.58Pivot S1−3.1%
$1.32Swing low (Jul 24)−19.0%
$1.0752 week low−34.4%
Indicators
RSI (14)
35.29
Weak, oversold below 30
Neutral
MACD
-0.11
Below its signal line
Bearish
Stochastic
5.3
Near the bottom of its range
Oversold
ADX (14)
23.1
Weak trend
Williams %R
-98.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-134.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−27.7%
Change over 10 sessions
Bearish
ATR (14)
$0.25
Typical daily range, 15.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
Bounce inside a longer downtrend
Short trendBullish
Long trendBearish
MomentumImproving
StretchNormal
VolatilityHigh, 27.6%/day
Key levels
$3.4452 week high+111.0%
$2.2320 day average+36.8%
$2.0550 day average+25.8%
$1.77Swing high (Jun 4)+8.6%
$1.71100 day average+4.9%
$1.70Pivot R1+4.3%
$1.66Pivot+1.8%
$1.63Last close
$1.60200 day average−1.8%
$1.58Pivot S1−3.1%
$1.32Swing low (Jul 24)−19.0%
$1.0752 week low−34.4%
Indicators
RSI (14)
48.31
Middle of its range
Neutral
MACD
0.15
Above its signal line
Bullish
Stochastic
36.6
Middle of its range
Neutral
ADX (14)
31.2
Trending up
Williams %R
-78.0
Oversold below −80, overbought above −20
Neutral
CCI (20)
7.7
Oversold below −100, overbought above 100
Neutral
Rate of change
+25.4%
Change over 10 sessions
Bullish
ATR (14)
$0.45
Typical daily range, 27.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Below
What happened before, for PACB
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how PACB did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow PACB usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for PACBHow many large options trades hit PACB, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in PACB in the last 90 days.
From SEC Form 4 filings by PACB's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PACB is in one of them and how their past PACB trades turned out.
Pacific Biosciences is a life science technology company based in Menlo Park, California, that designs and makes DNA sequencing systems. Its offerings include sequencing instruments, nanofluidic chips, reagents, software and sequencing services that read long stretches of DNA with high accuracy. Its customers include academic and government research institutions, clinical and testing laboratories, hospitals, public health labs, pharmaceutical companies, contract research organizations and agricultural companies.